Gares V, Panico L, Castagne R, Delpierre C, Kelly-Irving M. The role of the early social environment on Epstein Barr virus infection: a prospective observational design using the Millennium Cohort Study. Epidemiol Infect. 2017;145:3405–12.

Article  CAS  PubMed  Google Scholar 

Dunmire SK, Hogquist KA, Balfour HH. Infectious mononucleosis. Curr Top Microbiol Immunol. 2015;390:211–40.

CAS  PubMed  PubMed Central  Google Scholar 

Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362:1993–2000.

Article  CAS  PubMed  Google Scholar 

Tanner J, Weis J, Fearon D, Whang Y, Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell. 1987;50:203–13.

Article  CAS  PubMed  Google Scholar 

Haan KM, Kwok WW, Longnecker R, Speck P. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J Virol. 2000;74:2451–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Bu W, Gabriel E, et al. HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells. JCI Insight. 2017;2:e85687.

Article  PubMed  PubMed Central  Google Scholar 

Correia S, Bridges R, Wegner F, et al. Sequence variation of Epstein-Barr virus: viral types, geography, codon usage, and diseases. J Virol. 2018;92:e01132.

Coleman CB, Lang J, Sweet LA, et al. Epstein-Barr virus type 2 infects T cells and induces B cell lymphomagenesis in humanized mice. J Virol. 2018;92:e00813.

Coleman CB, Wohlford EM, Smith NA, et al. Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. J Virol. 2015;89:2301–12.

Article  PubMed  Google Scholar 

Torii Y, Kawada JI, Murata T, Yoshiyama H, Kimura H, Ito Y. Epstein-Barr virus infection-induced inflammasome activation in human monocytes. PLoS ONE. 2017;12:e0175053.

Article  PubMed  PubMed Central  Google Scholar 

Pisano G, Roy A, Ahmed Ansari M, Kumar B, Chikoti L, Chandran B. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency. Virol J. 2017;14:221.

Article  PubMed  PubMed Central  Google Scholar 

Chiang JJ, Sparrer KMJ, van Gent M, et al. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol. 2018;19:53–62.

Article  CAS  PubMed  Google Scholar 

• Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: biology and clinical disease. Cell. 2022;185:3652–70. A recent review highlighting EBV viology and immunology. Neoplastic and autoimmune diseaese associated with EBV infection are also discussed.

Article  CAS  PubMed  Google Scholar 

Tangye SG, Palendira U, Edwards ES. Human immunity against EBV-lessons from the clinic. J Exp Med. 2017;214:269–83.

Article  PubMed  PubMed Central  Google Scholar 

Balfour HH Jr, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2013;207:80–8.

Article  CAS  PubMed  Google Scholar 

Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787–821.

Article  CAS  PubMed  Google Scholar 

Long HM, Chagoury OL, Leese AM, et al. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J Exp Med. 2013;210:933–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol: Off J Eur Soc Med Oncol. 2009;20:1472–82.

Article  CAS  Google Scholar 

Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease. Front Immunol. 2017;8:1867.

Article  PubMed  PubMed Central  Google Scholar 

Bollard CM, Cohen JI. How I treat T-cell chronic active Epstein-Barr virus disease. Blood. 2018;131:2899–905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yonese I, Sakashita C, Imadome KI, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020;4:2918–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527–33.

Article  PubMed  Google Scholar 

Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988;157:405–12.

Article  CAS  PubMed  Google Scholar 

Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280–6.

Article  CAS  PubMed  Google Scholar 

Ito Y, Suzuki M, Kawada J, Kimura H. Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease. J Infect Chemother. 2016;22:268–71.

Article  PubMed  Google Scholar 

Kawada JI, Kamiya Y, Sawada A, et al. Viral DNA loads in various blood components of patients with Epstein-Barr virus-positive T-cell/natural killer cell lymphoproliferative diseases. J Infect Dis. 2019;220:1307–11.

Article  CAS  PubMed  Google Scholar 

Kimura H, Hoshino Y, Hara S, et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis. 2005;191:531–9.

Article  CAS  PubMed  Google Scholar 

Arai A. Advances in the study of chronic active Epstein-Barr virus infection: clinical features under the 2016 WHO Classification and Mechanisms of Development. Front Pediatr. 2019;7:14.

Article  PubMed  PubMed Central  Google Scholar 

Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673–86.

Article  CAS  PubMed  Google Scholar 

Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P, Fournié JJ. Acquisition of viral receptor by NK cells through immunological synapse. J Immunol. 2003;170:5993–8.

Article  CAS  PubMed  Google Scholar 

Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 1995;85:744–50.

Article  CAS  PubMed  Google Scholar 

•• Okuno Y, Murata T, Sato Y, et al. Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4:404–13. A comprehensive genetic analysis showing driver mutations and EBV deletions in pateints with CAEBV.

Article  CAS  PubMed  Google Scholar 

Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA. 1993;90:9150–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gregory CD, Dive C, Henderson S, et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 1991;349:612–4.

Article  CAS  PubMed  Google Scholar 

Kimura H. EBV in T-/NK-cell tumorigenesis. Adv Exp Med Biol. 2018;1045:459–75.

Article  CAS  PubMed  Google Scholar 

Iwata S, Yano S, Ito Y, et al. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection. Int J Cancer. 2011;129:2263–73.

Article  CAS  PubMed  Google Scholar 

Kawada J, Ito Y, Iwata S, et al. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. Clin Cancer Res. 2014;20:5412–22.

Article  CAS  PubMed  Google Scholar 

Ando S, Kawada JI, Watanabe T, et al. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. Oncotarget. 2016;7:76793–805.

Article  PubMed  PubMed Central  Google Scholar